LFCR

LFCR CapEx to Revenue

3.16%TTM

Retrieved:

LFCR FY CapEx/Revenue%
LFCR FY CapEx/Revenue30.14%-3.23%
1996-10-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

LFCR capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 31 observations from Oct 31, 1996 to Dec 31, 2025.

Lifecore Biomedical Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
4.894%
10.41%
14.3418%
20.802%
26.9075%
25.0045%
16.6719%
8.0232%
6.4075%
4.2446%
7.5526%
3.2472%
3.122%
2.0097%
1.6914%
2.4154%
18.8369%
1.9395%
1.7776%
3.2219%
2.0461%
1.7824%
1.7663%
0%
1.3901%
3.6467%
2.5474%
11.5819%
13.4328%
13.6842%
16%

Compare capex to revenue

All LFCR financial metrics · LFCR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.